Hospice News
FEBRUARY 20, 2024
Having a window into priorities such as career development and work-life balance is a significant retention factor for the Dallas-based home health and hospice company, Marion indicated. This is down from 54% of respondents in 2023’s survey and 68% of 2022 respondents. 2024 Hospice News Outlook Survey and Report.
Hospice News
JUNE 29, 2023
Addus HomeCare Corp. NASDAQ: ADUS) has reached an agreement to purchase the home health, hospice and private duty operator Tennessee Quality Care for $106 million. About 70% of its business is home health, including private duty, with hospice care comprising 30%. The company’s net service revenue reached $251.6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
SEPTEMBER 2, 2022
While a range of publicly traded companies and private equity firms have nevertheless snapped up hospices in record numbers, the skyrocketing valuations have led some to wait it out for a price drop. NYSE: CHEM), and the nation’s largest hospice company by market share, according to LexisNexis.
Hospice News
NOVEMBER 14, 2022
Labor shortages and other headwinds have battered hospices during 2022, including large companies. This has been a longstanding problem since the start of the pandemic, but average length of stay among the publicly traded firms tumbled at a faster rate in Q3 2022 (3%) than they did in the third quarter of 2021 (2%).
Hospice News
DECEMBER 19, 2022
In 2022, the hospice community laid the groundwork for a transformational 2023. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. 3–6 Big Provider, Payer Hospice Deals.
Hospice News
DECEMBER 12, 2022
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. s (NYSE: HUM) $2.8
Expert insights. Personalized for you.
197 
Let's personalize your content